学校法人近畿大学 近畿大学病院は、大阪府大阪狭山市にある近畿大学医学部の附属病院。略称は近大病院。大阪府南部唯一の大学病院であり、地域医療の中核的な役割を担う。

During the past decade, Kindai University Hospital conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 18 clinical trials were completed, i.e. on average, 43.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 17 clinical trials were completed. i.e. 89.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kindai University Hospital" #1 sponsor was "Pfizer" with 14 trials, followed by "Takeda" with 8 trials sponsored, "Bayer" with 5 trials sponsored, "Incyte Corporation" with 3 trials sponsored and "Merck Sharp & Dohme LLC" with 3 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kindai University Hospital" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Brightech International" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Kindai University Hospital" are "Prostatic Neoplasms" (4 trials), "Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials), "Myelodysplastic Syndrome" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Kindai University Hospital" in a lesser frequency.

Most popular intervention types in "Kindai University Hospital" are "Drug" (40 trials), "Biological" (5 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (6 trials), "Placebo" (6 trials), "Avelumab" (3 trials), "Epacadostat" (3 trials) and "Prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kindai University Hospital" are 32 trials for "All" genders, 7 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Kindai University Hospital". undefined are not yet recruiting, 7 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Kindai University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kindai University Hospital, 6 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".